Go Pro

Billiontoone (BLLN) Competitors

Billiontoone logo
$143.37 +6.05 (+4.40%)
As of 02:56 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BLLN vs. GH, BTSG, FMS, HIMS, and PACS

Should you buy Billiontoone stock or one of its competitors? MarketBeat compares Billiontoone with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Billiontoone include Guardant Health (GH), BrightSpring Health Services (BTSG), Fresenius Medical Care AG & Co. KGaA (FMS), Hims & Hers Health (HIMS), and PACS Group (PACS).

How does Billiontoone compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, earnings, institutional ownership, media sentiment, profitability, valuation and analyst recommendations.

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Billiontoone has a net margin of 0.00% compared to Guardant Health's net margin of -38.33%.

Company Net Margins Return on Equity Return on Assets
Guardant Health-38.33% N/A -25.40%
Billiontoone N/A N/A N/A

Guardant Health currently has a consensus price target of $183.78, suggesting a potential upside of 15.23%. Billiontoone has a consensus price target of $126.00, suggesting a potential downside of 12.11%. Given Guardant Health's stronger consensus rating and higher possible upside, analysts clearly believe Guardant Health is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
23 Buy rating(s)
1 Strong Buy rating(s)
2.96
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Billiontoone has lower revenue, but higher earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M21.80-$416.28M-$3.49N/A
Billiontoone$305.11M21.61$7.45M$0.55260.67

In the previous week, Guardant Health had 32 more articles in the media than Billiontoone. MarketBeat recorded 38 mentions for Guardant Health and 6 mentions for Billiontoone. Guardant Health's average media sentiment score of 0.93 beat Billiontoone's score of 0.69 indicating that Guardant Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
18 Very Positive mention(s)
2 Positive mention(s)
12 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Guardant Health beats Billiontoone on 9 of the 15 factors compared between the two stocks.

How does Billiontoone compare to BrightSpring Health Services?

Billiontoone (NASDAQ:BLLN) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

BrightSpring Health Services has higher revenue and earnings than Billiontoone. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M21.61$7.45M$0.55260.67
BrightSpring Health Services$12.91B0.96$190.67M$1.6637.88

In the previous week, BrightSpring Health Services had 16 more articles in the media than Billiontoone. MarketBeat recorded 22 mentions for BrightSpring Health Services and 6 mentions for Billiontoone. BrightSpring Health Services' average media sentiment score of 0.80 beat Billiontoone's score of 0.69 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
7 Very Positive mention(s)
1 Positive mention(s)
11 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Billiontoone currently has a consensus target price of $126.00, indicating a potential downside of 12.11%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 12.45%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
BrightSpring Health Services
0 Sell rating(s)
1 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
3.00

BrightSpring Health Services has a net margin of 2.55% compared to Billiontoone's net margin of 0.00%. BrightSpring Health Services' return on equity of 16.73% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
BilliontooneN/A N/A N/A
BrightSpring Health Services 2.55%16.73%5.24%

Summary

BrightSpring Health Services beats Billiontoone on 12 of the 14 factors compared between the two stocks.

How does Billiontoone compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Billiontoone. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA$22.20B0.58$1.11B$1.9012.59
Billiontoone$305.11M21.61$7.45M$0.55260.67

In the previous week, Fresenius Medical Care AG & Co. KGaA had 7 more articles in the media than Billiontoone. MarketBeat recorded 13 mentions for Fresenius Medical Care AG & Co. KGaA and 6 mentions for Billiontoone. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.86 beat Billiontoone's score of 0.69 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fresenius Medical Care AG & Co. KGaA
7 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Billiontoone
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.88% compared to Billiontoone's net margin of 0.00%. Fresenius Medical Care AG & Co. KGaA's return on equity of 8.90% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Fresenius Medical Care AG & Co. KGaA4.88% 8.90% 4.05%
Billiontoone N/A N/A N/A

Fresenius Medical Care AG & Co. KGaA currently has a consensus price target of $23.95, suggesting a potential upside of 0.13%. Billiontoone has a consensus price target of $126.00, suggesting a potential downside of 12.11%. Given Fresenius Medical Care AG & Co. KGaA's higher probable upside, equities analysts clearly believe Fresenius Medical Care AG & Co. KGaA is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Summary

Fresenius Medical Care AG & Co. KGaA beats Billiontoone on 10 of the 15 factors compared between the two stocks.

How does Billiontoone compare to Hims & Hers Health?

Hims & Hers Health (NYSE:HIMS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, profitability, analyst recommendations and earnings.

In the previous week, Hims & Hers Health had 20 more articles in the media than Billiontoone. MarketBeat recorded 26 mentions for Hims & Hers Health and 6 mentions for Billiontoone. Billiontoone's average media sentiment score of 0.69 beat Hims & Hers Health's score of 0.24 indicating that Billiontoone is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
4 Very Positive mention(s)
3 Positive mention(s)
11 Neutral mention(s)
5 Negative mention(s)
3 Very Negative mention(s)
Neutral
Billiontoone
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Hims & Hers Health currently has a consensus target price of $31.43, indicating a potential downside of 1.49%. Billiontoone has a consensus target price of $126.00, indicating a potential downside of 12.11%. Given Hims & Hers Health's higher probable upside, equities analysts clearly believe Hims & Hers Health is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
1 Sell rating(s)
11 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.19
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

Hims & Hers Health has higher revenue and earnings than Billiontoone. Hims & Hers Health is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$2.35B3.15$128.37M-$0.09N/A
Billiontoone$305.11M21.61$7.45M$0.55260.67

63.5% of Hims & Hers Health shares are owned by institutional investors. 11.8% of Hims & Hers Health shares are owned by insiders. Comparatively, 50.2% of Billiontoone shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Billiontoone has a net margin of 0.00% compared to Hims & Hers Health's net margin of -0.56%. Hims & Hers Health's return on equity of 6.10% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health-0.56% 6.10% 1.52%
Billiontoone N/A N/A N/A

Summary

Billiontoone beats Hims & Hers Health on 8 of the 15 factors compared between the two stocks.

How does Billiontoone compare to PACS Group?

PACS Group (NYSE:PACS) and Billiontoone (NASDAQ:BLLN) are both mid-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, institutional ownership, profitability, analyst recommendations, risk, valuation, dividends and media sentiment.

PACS Group presently has a consensus target price of $50.60, suggesting a potential upside of 12.03%. Billiontoone has a consensus target price of $126.00, suggesting a potential downside of 12.11%. Given PACS Group's stronger consensus rating and higher probable upside, equities research analysts clearly believe PACS Group is more favorable than Billiontoone.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
PACS Group
0 Sell rating(s)
2 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.71
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50

PACS Group has higher revenue and earnings than Billiontoone. PACS Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
PACS Group$5.29B1.35$191.54M$1.5628.95
Billiontoone$305.11M21.61$7.45M$0.55260.67

PACS Group has a net margin of 4.49% compared to Billiontoone's net margin of 0.00%. PACS Group's return on equity of 26.47% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
PACS Group4.49% 26.47% 4.36%
Billiontoone N/A N/A N/A

In the previous week, PACS Group had 2 more articles in the media than Billiontoone. MarketBeat recorded 8 mentions for PACS Group and 6 mentions for Billiontoone. PACS Group's average media sentiment score of 1.20 beat Billiontoone's score of 0.69 indicating that PACS Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
PACS Group
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Billiontoone
2 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

PACS Group beats Billiontoone on 10 of the 13 factors compared between the two stocks.

Get Billiontoone News Delivered to You Automatically

Sign up to receive the latest news and ratings for BLLN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BLLN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BLLN vs. The Competition

MetricBilliontooneHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$6.59B$9.91B$6.80B$13.01B
Dividend YieldN/A2.54%2.60%10.03%
P/E Ratio260.6825.66279.9825.51
Price / Sales21.614.86649.35116.02
Price / Cash428.2026.4428.6434.82
Price / Book13.685.2111.156.35
Net Income$7.45M$312.25M$3.48B$347.60M
7 Day Performance7.28%-0.80%2.51%3.14%
1 Month Performance19.13%-0.78%-2.78%-2.08%
1 Year PerformanceN/A25.08%64.32%21.27%

Billiontoone Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BLLN
Billiontoone
2.7318 of 5 stars
$143.37
+4.4%
$126.00
-12.1%
N/A$6.59B$305.11M260.68620
GH
Guardant Health
3.3966 of 5 stars
$147.33
-1.9%
$160.04
+8.6%
+283.5%$19.92B$1.08BN/A2,506
BTSG
BrightSpring Health Services
4.8414 of 5 stars
$72.91
+4.4%
$70.12
-3.8%
+207.9%$14.38B$13.65B51.7123,500
FMS
Fresenius Medical Care AG & Co. KGaA
3.9085 of 5 stars
$24.58
+0.6%
$28.00
+13.9%
+1.0%$13.13B$22.20B12.931,488
HIMS
Hims & Hers Health
2.2411 of 5 stars
$28.10
-14.2%
$31.43
+11.9%
-50.7%$7.58B$2.37BN/A2,442

Related Companies and Tools


This page (NASDAQ:BLLN) was last updated on 8/4/2026 by MarketBeat.com Staff.
From Our Partners